Home › Funds › SATURNA CAPITAL CORP › ABBV

SATURNA CAPITAL CORP position in ABBV

ABBVIE INC · Health Care

SATURNA CAPITAL CORP reported holding 958,069 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$240.6M, representing 2.94% of its reported portfolio and ranking #11 among its reported holdings. SATURNA CAPITAL CORP has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)958.07K sh
Reported value held$240.56M
Portfolio Weight2.94%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SATURNA CAPITAL CORP's ABBV position evolved

SATURNA CAPITAL CORP first disclosed a stake in ABBV in Q3 2023 at 113,468 shares (US$16.9M). The position peaked in Q2 2026 at 958,069 shares, worth US$240.6M. Across 12 filings, SATURNA CAPITAL CORP increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 958,069 shares valued at US$240.6M — an increase of 176,398 shares quarter over quarter.. Notable position changes include a 486% increase in Q3 2024 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 113.47K $16.91M New
Q4 2023 114.77K $17.79M Add
Q1 2024 115.37K $21.01M Add
Q2 2024 115.37K $19.79M Hold
Q3 2024 676.18K $133.53M Add
Q4 2024 676.66K $120.24M Hold
Q1 2025 717.19K $150.26M Add
Q2 2025 719.01K $133.46M Hold
Q3 2025 749.15K $173.46M Add
Q4 2025 780.29K $178.29M Add
Q1 2026 781.67K $170.01M Hold
Q2 2026 958.07K $240.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has SATURNA CAPITAL CORP held ABBV?

SATURNA CAPITAL CORP has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SATURNA CAPITAL CORP's current position in ABBV?

As of Q2 2026, SATURNA CAPITAL CORP holds 958.07K shares of ABBV (ABBVIE INC), valued at $240.56M, representing 2.94% of its reported portfolio and ranking #11.

Has SATURNA CAPITAL CORP been buying or selling ABBV?

In the latest 13F filing (Q2 2026), SATURNA CAPITAL CORP increased its position in ABBV. The position peaked in Q2 2026 at 958.07K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.